MakeMyTrip Ltd vs Altria Group Inc — how do they compare? MakeMyTrip Ltd trades at $60.21 (market cap $5.78B), while Altria Group Inc trades at $64.98 (market cap $108.58B). The key difference: Altria Group Inc is far larger — about 18.8× MakeMyTrip Ltd's market cap, and Altria Group Inc pays a 6.52% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals.
| MMYT | MO | |
|---|---|---|
Market Cap | $5.78B | $108.58B |
Sector | Technology | Consumer Staples |
52-Week High | $103.21 | $74.92 |
52-Week Low | $36.30 | $54.72 |
Enterprise Value | $6.44B | $130.79B |
Dividend Yield | — | 6.52% |
Signals from Pluang's Aura AI — not financial advice
MakeMyTrip (MMYT) trades at $60.70, down 0.34% with a bullish technical signal supported by moving averages. The company reported strong Q1 2027 earnings with revenue growth in hotels and packages offsetting air-ticketing softness. Analysts maintain a 72.7% buy rating with a 34.1% upside target. Recent financials show $978M revenue and $95M net income for 2025, though 2026 projections indicate margin compression.
The stock presents growth potential driven by travel recovery and platform diversification, but faces risks from geopolitical disruptions, fuel costs, and rising debt levels. Current valuation metrics (P/E 267, P/S 6.07) suggest premium pricing requiring sustained execution. Institutional sentiment remains positive despite recent selling by Boston Common Asset Management.
Altria Group (MO) trades at $64.83, down 1.08% on the day, with a bearish technical signal but strong fundamentals including a 39% net income margin and a P/E of 13.69. Recent earnings showed mixed results, with Q1 2026 beating expectations but Q2 missing. The company maintains robust cash flow from operations of $9.29 billion in 2025 and a dividend yield of approximately 6.3%, with a payout scheduled for July 2026. Analyst consensus is bullish with a $67 price target, though legal investigations and cigarette volume declines pose headwinds.
Outlook: MO offers value through dividends and stable cash flows, but faces risks from regulatory pressures and declining smokable product demand. Investment opportunity lies in its smoke-free transition and pricing power, yet investors must weigh litigation risks and market sentiment shifts. Near-term price movement may hinge on Q3 2026 earnings and dividend announcements.
Trailing returns across standard periods
Latest headlines on both assets
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →